Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications.

Revisions in the International System for Staging Lung Cancer

1997 • 4,582 citations

Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer

1995 • 2,739 citations

Incidence of local recurrence and second primary tumors in resected stage I lung cancer

1995 • 971 citations

K-rasOncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung

1990 • 811 citations

p185neu expression in human lung adenocarcinomas predicts shortened survival.

1990 • 440 citations

Accumulation of p53 protein correlates with a poor prognosis in human lung cancer.

1992 • 384 citations

Immunocytochemical markers in stage I lung cancer: relevance to prognosis.

1997 • 313 citations

Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer.

1989 • 275 citations

ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent.

1991 • 249 citations

Correlation of Expression of H/Le^Y/Le^BAntigens with Survival in Patients with Carcinoma of the Lung

1992 • 235 citations

Expression of Blood-Group Antigen A — A Favorable Prognostic Factor in Non-Small-Cell Lung Cancer

1991 • 221 citations

Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma

1991 • 185 citations

ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis.

1992 • 168 citations

Detection of K-ras mutations in lung carcinomas: Relationship to prognosis

1996 • 166 citations

Angiogenesis and molecular biologic substaging in patients with stage I non—small cell lung cancer

1996 • 136 citations

Altered Retinoblastoma Protein Expression and Prognosis in Early-Stage Non-Small-Cell Lung Carcinoma

1994 • 130 citations

p53 Immunostaining Positivity Is Associated With Reduced Survival and Is Imperfectly Correlated With Gene Mutations in Resected Non-small Cell Lung Cancer

1994 • 118 citations

Prognostic significance of the expression ofras oncogene product in non-small cell lung cancer

1992 • 98 citations

Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes.

1989 • 83 citations

The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.

1994 • 76 citations

Non-small cell lung cancer: clinical value of new biological predictors

1997 • 75 citations

Prognostic factors in resected stages I and II adenocarcinoma of the lung

1990 • 58 citations

Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.

1991 • 57 citations

Prognostic significance of parenchymal lymphatic vessel and blood vessel invasion in carcinoma of the lung.

1983 • 34 citations

Mutated K-ras gene analysis in a randomized trial of preoperative chemotherapy plus surgery versus surgery in Stage IIIA non-small cell lung cancer

1995 • 23 citations